Jared S. Hopkins

The pharmaceutical company reported its third consecutive quarter with positive results.

The pharmaceutical company reported its third consecutive quarter with positive results.

The pharmaceutical company raised its revenue outlook for the year to between $61 billion to $64 billion, up from $59.5 billion to $62.5 billion previously.

U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.

U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.

The French company looks to rein in how it gives discounts in a federal program designed to help hospitals that serve low-income and uninsured patients.

Middlemen negotiate prescription costs at thousands of different price points, depending on your insurance plan.

Middlemen negotiate widely different prices for prescriptions, depending on your Medicare insurance plan.

The cost of prescription drugs in the U.S. isn’t like the tabs for other products. The price for a single medicine can range by thousands of dollars depending on the drug plan.

Shares of the parent companies of pharmacy benefit managers fell Tuesday after President-elect Donald Trump and others indicated that the new administration planned to crack down on the business. Shares of UnitedHealth were down 3.3% while Cigna and CVS Health shares fell 2.6% and 4.4% respectively